Amazing down over $.30 at one point today. Guess they needed to increase profit 3x. 2x increase is bad news.
buying opportunity. i already own this but will get out of another pharma to move into jnj with post earnings weakness. looking for 100 plus later in the year.
Good choice. JNJ has been too solid to pass up for me too.
I completely don't get it. Might be the macro move affecting JNJ?